Physician profile
John V Tedesco
NPI 1790951747
$1,739.48
in general payments reported to CMS, 2019-2025
12 companies · $558 in 2025
The $558 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $133 · 2021: $317 · 2022: $181 · 2023: $125 · 2024: $427 · 2025: $558.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $585 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $350 · Food and Beverage: $174.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $585.25 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $350.00 |
| Food and Beverage | $174.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $525.25 | 2025 | |
| Becton, Dickinson and Company | $350.00 | 2024 | |
| Organogenesis INC. | $292.96 | 2021-2023 | Puraply |
| Medtronic, INC. | $195.37 | 2022-2024 | Nuvent, Plasmablade(Tm) |
| Pacira Pharmaceuticals Incorporated | $139.84 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $70.21 | 2022-2023 | Seglentis |
| Allergan, INC. | $61.31 | 2019-2021 | |
| Smith+Nephew, INC. | $37.54 | 2023 | Grafix |
| Vertex Pharmaceuticals Incorporated | $32.25 | 2025 | |
| Davol INC. | $17.91 | 2023 | Phasix Mesh |
| Tela Bio, INC. | $16.84 | 2024 | Ovitex 2s |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Tedesco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.